These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3685042)

  • 41. Studies of the pathogenic mechanisms of light on rat retina.
    Lai YL; Lug R; Yao PC; Hayasaka S; Hayasaka I
    Acta Anat (Basel); 1980; 107(4):407-17. PubMed ID: 7405529
    [No Abstract]   [Full Text] [Related]  

  • 42. Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings.
    Rahi AH; Hungerford JL; Ahmed AI
    Br J Ophthalmol; 1986 May; 70(5):373-81. PubMed ID: 3964637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pigmentary changes of the retina in dialysis patients treated with deferoxamine].
    Mathys B; Baeck A; Verougstraete C; Verstappen A; D'Haene M; Zanen A
    Bull Soc Belge Ophtalmol; 1988; 229():49-60. PubMed ID: 3273254
    [No Abstract]   [Full Text] [Related]  

  • 44. Neural retinal and pigment epithelial cells in culture: patterns of differentiation and effects of prostaglandins and cyclic-AMP on pigmentation.
    Redfern N; Israel P; Bergsma D; Robison WG; Whikehart D; Chader G
    Exp Eye Res; 1976 May; 22(5):559-68. PubMed ID: 179835
    [No Abstract]   [Full Text] [Related]  

  • 45. Down-regulation of senescence marker protein 30 by iron-specific chelator deferoxamine drives cell senescence.
    Inoue H; Hanawa N; Katsumata-Tsuboi R; Katsumata SI; Takahashi N; Uehara M
    Biosci Biotechnol Biochem; 2018 May; 82(5):900-903. PubMed ID: 29490582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antioxidant and iron-chelating agents in cerebral vasospasm.
    Luo Z; Harada T; London S; Gajdusek C; Mayberg MR
    Neurosurgery; 1995 Dec; 37(6):1154-8; discussion 1158-9. PubMed ID: 8584156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of retinal susceptibility to light damage in pigmented rats supplemented with beta-carotene.
    Rapp LM; Fisher PL; Suh DW
    Curr Eye Res; 1996 Feb; 15(2):219-23. PubMed ID: 8670732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The severity of copper deficiency can be ameliorated by deferoxamine.
    Fields M; Lewis CG; Lure MD; Burns WA; Antholine WE
    Metabolism; 1991 Jan; 40(1):105-9. PubMed ID: 1845818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of argon laser photoradiation on the monkey retina treated with hematoporphyrin derivative--an electron microscopic study].
    Ohnishi Y; Yamana Y; Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1984 Nov; 88(11):1389-96. PubMed ID: 6543289
    [No Abstract]   [Full Text] [Related]  

  • 50. Iron chelator deferoxamine induces epithelial transformation of tumor cells.
    Rubtsova SN; Vasilev YM
    Dokl Biol Sci; 2006; 411():517-9. PubMed ID: 17425058
    [No Abstract]   [Full Text] [Related]  

  • 51. [Metaplastic changes to fibroblast-like cells by retinal pigment epithelium].
    Ogata N; Kanai K; Ohkuma H; Uyama M
    Nippon Ganka Gakkai Zasshi; 1988 Dec; 92(12):2029-37. PubMed ID: 3239506
    [No Abstract]   [Full Text] [Related]  

  • 52. Changes in ultrastructure and function of the sheep pigment epithelium and retina induced by sodium iodate. III. Delayed effects.
    Nilsson SE; Knave B; Persson HE
    Acta Ophthalmol (Copenh); 1977 Dec; 55(6):1027-43. PubMed ID: 579542
    [No Abstract]   [Full Text] [Related]  

  • 53. Unexpected effects of albumin on apoptosis induction by deferoxamine in vitro.
    Kovár J; Kemp JD
    In Vitro Cell Dev Biol Anim; 2000 Mar; 36(3):151-2. PubMed ID: 10777053
    [No Abstract]   [Full Text] [Related]  

  • 54. Deferoxamine effects on Plasmodium falciparum gene expression.
    Moormann AM; Hossler PA; Meshnick SR
    Mol Biochem Parasitol; 1999 Jan; 98(2):279-83. PubMed ID: 10080396
    [No Abstract]   [Full Text] [Related]  

  • 55. Bilateral vitelliform maculopathy and deferoxamine toxicity.
    Gonzales CR; Lin AP; Engstrom RE; Kreiger AE
    Retina; 2004 Jun; 24(3):464-7. PubMed ID: 15187676
    [No Abstract]   [Full Text] [Related]  

  • 56. [The effect of deferoxamine (Fe3+-chelating agent) on in-vitro rabbit retinas (author's transl)].
    Negi A; Honda Y; Mitsuyu M
    Nippon Ganka Gakkai Zasshi; 1979 Jan; 83(1):1-4. PubMed ID: 443114
    [No Abstract]   [Full Text] [Related]  

  • 57. Pigment aggregation by melatonin in the retinal pigment epithelium and choroid of guinea-pigs, Caviaporcellus.
    Pang SF; Yew DT
    Experientia; 1979 Feb; 35(2):231-3. PubMed ID: 421842
    [No Abstract]   [Full Text] [Related]  

  • 58. [Animal experiment studies of the retinotoxic effect of low-level lead concentrations].
    Hennekes R; Janssen K
    Fortschr Ophthalmol; 1987; 84(4):374-6. PubMed ID: 3666633
    [No Abstract]   [Full Text] [Related]  

  • 59. Desferrioxamine administered intravenously by infusion causes a reduction in the electroretinogram in rabbits anaesthetized with urethane.
    Arden GB
    Hum Toxicol; 1986 Jul; 5(4):229-36. PubMed ID: 3733112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toxic effects of ornithine and its related compounds on the retina.
    Ishikawa Y; Kuwabara T; Kaiser-Kupfer MI
    Adv Exp Med Biol; 1982; 153():371-8. PubMed ID: 6131576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.